These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 27701453)

  • 1. Plasma Pentosidine and Its Association with Mortality in Patients with Chronic Kidney Disease.
    Machowska A; Sun J; Qureshi AR; Isoyama N; Leurs P; Anderstam B; Heimburger O; Barany P; Stenvinkel P; Lindholm B
    PLoS One; 2016; 11(10):e0163826. PubMed ID: 27701453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma pentosidine is associated with inflammation and malnutrition in end-stage renal disease patients starting on dialysis therapy.
    Suliman ME; Heimbürger O; Bárány P; Anderstam B; Pecoits-Filho R; Rodríguez Ayala E; Qureshi AR; Fehrman-Ekholm I; Lindholm B; Stenvinkel P
    J Am Soc Nephrol; 2003 Jun; 14(6):1614-22. PubMed ID: 12761263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma S100A12 and soluble receptor of advanced glycation end product levels and mortality in chronic kidney disease Stage 5 patients.
    Isoyama N; Leurs P; Qureshi AR; Bruchfeld A; Anderstam B; Heimburger O; Bárány P; Stenvinkel P; Lindholm B
    Nephrol Dial Transplant; 2015 Jan; 30(1):84-91. PubMed ID: 25074436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma pentosidine and total homocysteine levels in relation to change in common carotid intima-media area in the first year of dialysis therapy.
    Suliman ME; Stenvinkel P; Jogestrand T; Maruyama Y; Qureshi AR; Bárány P; Heimbürger O; Lindholm B
    Clin Nephrol; 2006 Dec; 66(6):418-25. PubMed ID: 17176913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelial dysfunction and low-grade inflammation in the transition to renal replacement therapy.
    Gennip ACEV; Broers NJH; Meulen KJT; Canaud B; Christiaans MHL; Cornelis T; Gelens MACJ; Hermans MMH; Konings CJAM; Net JBV; Sande FMV; Schalkwijk CG; Stifft F; Wirtz JJJM; Kooman JP; Martens RJH
    PLoS One; 2019; 14(9):e0222547. PubMed ID: 31518378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating levels and dietary intake of the advanced glycation end-product marker carboxymethyl lysine in chronic kidney disease patients on conservative predialysis therapy: a pilot study.
    Piroddi M; Palazzetti I; Quintaliani G; Pilolli F; Montaldi M; Valentina V; Libetta C; Galli F
    J Ren Nutr; 2011 Jul; 21(4):329-39. PubMed ID: 21193322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self-rated appetite as a predictor of mortality in patients with stage 5 chronic kidney disease.
    Gama-Axelsson T; Lindholm B; Bárány P; Heimbürger O; Stenvinkel P; Qureshi AR
    J Ren Nutr; 2013 Mar; 23(2):106-13. PubMed ID: 22739657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of gender, weight, height and BMI on pentosidine concentrations in plasma of hemodialyzed patients.
    Slowick-Zylka D; Safranow K; Dziedziejko V; Dutkiewicz G; Ciechanowski K; Chlubek D
    J Nephrol; 2006; 19(1):65-9. PubMed ID: 16523428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum 8-hydroxydeoxyguanosine, a marker of oxidative DNA damage, is associated with mortality independent of inflammation in chronic kidney disease.
    Dai L; Watanabe M; Qureshi AR; Mukai H; Machowska A; Heimbürger O; Barany P; Lindholm B; Stenvinkel P
    Eur J Intern Med; 2019 Oct; 68():60-65. PubMed ID: 31402276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of hepatitis C and iron replacement therapy on plasma pentosidine levels in haemodialysis patients.
    Nascimento MM; Suliman ME; Bruchfeld A; Hayashi SY; Manfro RC; Qureshi AR; Pecoits-Filho R; Pachaly MA; Renner L; Stenvinkel P; Riella MC; Lindholm B
    Nephrol Dial Transplant; 2004 Dec; 19(12):3112-6. PubMed ID: 15466879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating vascular endothelial growth factor (VEGF) and its soluble receptor 1 (sVEGFR-1) are associated with inflammation and mortality in incident dialysis patients.
    Yuan J; Guo Q; Qureshi AR; Anderstam B; Eriksson M; Heimbürger O; Bárány P; Stenvinkel P; Lindholm B
    Nephrol Dial Transplant; 2013 Sep; 28(9):2356-63. PubMed ID: 23828162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of hemodialysis membrane type on pentosidine plasma level, a marker of "carbonyl stress".
    Jadoul M; Ueda Y; Yasuda Y; Saito A; Robert A; Ishida N; Kurokawa K; Van Ypersele De Strihou C; Miyata T
    Kidney Int; 1999 Jun; 55(6):2487-92. PubMed ID: 10354298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adipokines, endothelial dysfunction and nutritional status in peritoneal dialysis patients.
    Małgorzewicz S; Lichodziejewska-Niemierko M; Aleksandrowicz-Wrona E; Świetlik D; Rutkowski B; Łysiak-Szydłowska W
    Scand J Urol Nephrol; 2010 Dec; 44(6):445-51. PubMed ID: 20624111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylglyoxal as a prognostic factor in patients with chronic kidney disease.
    Tezuka Y; Nakaya I; Nakayama K; Nakayama M; Yahata M; Soma J
    Nephrology (Carlton); 2019 Sep; 24(9):943-950. PubMed ID: 30407693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of residual renal function on plasma levels of advanced oxidation protein products and pentosidine in peritoneal dialysis patients.
    Furuya R; Kumagai H; Odamaki M; Takahashi M; Miyaki A; Hishida A
    Nephron Clin Pract; 2009; 112(4):c255-61. PubMed ID: 19546585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skin autofluorescence, arterial stiffness and Framingham risk score as predictors of clinical outcome in chronic kidney disease patients: a cohort study.
    Mukai H; Svedberg O; Lindholm B; Dai L; Heimbürger O; Barany P; Anderstam B; Stenvinkel P; Qureshi AR
    Nephrol Dial Transplant; 2019 Mar; 34(3):442-448. PubMed ID: 29378035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of pitavastatin add-on therapy on chronic kidney disease with albuminuria and dyslipidemia.
    Ohsawa M; Tamura K; Wakui H; Kanaoka T; Azushima K; Uneda K; Haku S; Kobayashi R; Ohki K; Haruhara K; Kinguchi S; Toya Y; Umemura S
    Lipids Health Dis; 2015 Dec; 14():161. PubMed ID: 26645467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Handgrip strength is an independent predictor of renal outcomes in patients with chronic kidney diseases.
    Chang YT; Wu HL; Guo HR; Cheng YY; Tseng CC; Wang MC; Lin CY; Sung JM
    Nephrol Dial Transplant; 2011 Nov; 26(11):3588-95. PubMed ID: 21444362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of dialysis membrane type on plasma concentrations of pentosidine, a marker of carbonyl stress, in hemodialyzed patients.
    Słowik-Zyłka D; Safranow K; Dziedziejko V; Ciechanowski K; Dziewanowski K; Chlubek D
    Pol Arch Med Wewn; 2009 Oct; 119(10):614-20. PubMed ID: 19847136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of protein leaking BK-F PMMA-based hemodialysis on plasma pentosidine levels.
    Tessitore N; Lapolla A; Aricò NC; Poli A; Gammaro L; Bassi A; Bedogna V; Corgnati A; Reitano R; Fedele D; Lupo A
    J Nephrol; 2004; 17(5):707-14. PubMed ID: 15593039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.